Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biochemistry and Molecular Biology International|July 1, 1995
Hypoxia induces HSP 70 gene expression in human hepatoma (HEP G2) cellsB Patel, A Khaliq, J Jarvis-Evans, et al.
Atherosclerosis|February 1, 1991
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitusM I Mackness, D Harty, D Bhatnagar, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1990
Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patientsB C Lalor, D Bhatnagar, P H Winocour, et al.
Diabetes Research and Clinical Practice|December 1, 1992
A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitusP H Winocour, P N Durrington, D Bhatnagar, et al.
Atherosclerosis|March 1, 1992
The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemiaP H Winocour, P N Durrington, D Bhatagnar, et al.
Biochimica Et Biophysica Acta|July 20, 1990
Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic ratB N Patel, M I Mackness, D W Harty, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1990
Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitusP H Winocour, P N Durrington, D Bhatnagar, et al.
Atherosclerosis|July 25, 1998
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemiaP N Durrington, M I Mackness, D Bhatnagar, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populationsA D Mbewu, D Bhatnagar, P N Durrington, et al.
Atherosclerosis|August 26, 1998
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitusB Mackness, M I Mackness, S Arrol, et al.
Pageof 4